Zurück zu den Rankings

Nordson Corporation (NDSN)

POSITIVE
IndustrialsSpecialty Industrial MachineryUnited States

Fundamental

70

Kurs

$334.96

Marktkapitalisierung

$18.51B

Teil 1 · Was das Unternehmen wert ist

Übersicht

Nordson makes precision dispensing equipment: machines that apply exact, controlled amounts of adhesives, coatings, sealants and other fluids inside a factory line, plus components used in medical devices and semiconductor manufacturing. Its products are typically a small line item inside a much larger production process — a diaper plant's glue applicator, a chip packaging step, a catheter's plastic tubing — but a failure or imprecision there can shut the whole line down.

Wie das Geld verdient wird

Revenue comes mostly from selling dispensing systems and components once, plus recurring sales of spare parts, nozzles and service that keep those systems running precisely over years of use. Because customers integrate Nordson's equipment into a validated production process, replacing it later requires re-qualifying the whole line, which supports steady repeat business rather than one-off equipment sales.

Umsatz nach Segment

Industrial Precision Solutions48%

Adhesive, coating and sealant dispensing systems sold into packaging, general industrial and consumer goods production lines.

Medical and Fluid Solutions30%

Components and precision fluid-management systems used in medical devices such as catheters, plus fluid dispensing for other industries.

Advanced Technology Solutions22%

Equipment used in semiconductor and electronics manufacturing, including chip packaging and testing steps.

Wettbewerbsvorteil

Wechselkosten · Schmal

Once a customer validates a production line around Nordson's dispensing equipment — calibrated to exact fluid volumes and tolerances, sometimes under regulatory approval as in medical devices — swapping to a competitor means re-validating the whole line, a costly and slow process manufacturers avoid unless something is badly wrong. That keeps replacement parts and service revenue sticky even where the original equipment sale was competitive.

Was die Nachfrage antreibt

Mäßig zyklisch

Demand splits between steadier end markets — packaging, medical devices, consumer nondurables — and more cyclical ones like semiconductor and electronics capital spending, which swings with chip industry investment cycles. The mix of the three segments smooths some of that cyclicality but does not remove it, particularly in the Advanced Technology segment.

Wichtigste Risiken

  • Cyclicality in semiconductor capital spending — The Advanced Technology Solutions segment depends on chip makers' capital equipment budgets, which are historically volatile and can swing sharply between shortage and oversupply periods.
  • Acquisition integration risk — Nordson has grown its segments partly through acquisitions; integrating acquired businesses' operations, systems and customer relationships carries execution risk and can strain expected returns.
  • Customer capital spending decisions — Equipment sales depend on customers deciding to build or upgrade production lines, decisions that can be postponed in an uncertain economic environment even when replacement parts demand continues.
  • International operations and currency exposure — A significant share of sales and manufacturing occurs outside the United States, exposing results to currency translation and to economic and trade conditions in those markets.

Die Argumente dafür

Buyers argue that Nordson's equipment gets embedded in validated production lines across three diversified end markets, that recurring parts and service revenue smooths the cycle, and that record fiscal 2025 results show the model compounding through both steadier and more cyclical segments at once.

Die Argumente dagegen

Sellers fear that the Advanced Technology segment remains exposed to a genuinely volatile semiconductor capital-spending cycle, that growth built partly through acquisitions carries integration risk that can disappoint, and that a broader industrial slowdown would delay the equipment upgrades that drive the larger, steadier segments too.

Written by the editors, published on 18. August 2026

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Bilanz & Liquidität

Umsatz

$2.98B

Letzte 12 Monate (bis 31.7.2026)

Nettogewinn

$555M

Letzte 12 Monate (bis 31.7.2026)

Freier Cashflow

$661M

Gesamtes Eigenkapital

$3.04B

Gesamtverbindlichkeiten

$2.87B

Current Ratio

1.82

Zinsdeckungsgrad

8.83

Schulden/EBITDA

2.30

Gewinn je Aktie

Umsatz & Nettogewinn

Freier Cashflow

Ertragsaufschlüsselung

Historische Aufstellung

Margen im Zeitverlauf

Verschuldung im Zeitverlauf

Wie schwer die Schulden wiegen

Wachstumsraster

Wachstum — Umsatz

Innerer-Wert-Schätzung

Fair bewertet

Innerer Wert

$291.28

Aktueller Kurs

$334.96

Sicherheitsmarge

-15.0%

Innerer-Wert-Spanne

$219.91 - $362.64

Bewertungsmethoden

Analyst Target:$349.71
DCF:$316.90
PE-based:$236.73
Graham Growth:$331.27
EPV:$104.31
Analystenkonsens:Kaufen (10B / 5H / 0S)
Letzte Gewinnüberraschung:+2.66%

Bewertungskennzahlen

P/E-Verhältnis

33.83

ROE

15.9%

P/B-Verhältnis

5.69

P/FCF

25.69

Bruttomarge

55.3%

ROIC

12.1%

Rentabilitäts-Radar

Value Creation (Economic Moat)

ROIC

12.1%

WACC

9.5%

ROIC − WACC

+2.6 pp

ROIC exceeds the cost of capital — the company is creating value for shareholders.

Fundamentalanalyse-Kriterien

Bestanden (21)

  • EPS shows upward trend
  • EPS CAGR 5.49%
  • Price CAGR 11.48%
  • ROIC 12.1%
  • Gross Margin 55.3%
  • P/FCF 25.69
  • Debt/Equity ratio
  • Operating Margin 26.9%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 17.1%
  • Revenue Growth 5Y 5.7%
  • Analyst Consensus 67% Buy
  • Earnings Quality (OCF/NI) 1.39
  • Share Dilution -1.2%
  • Net Margin Trend 18.6% vs 16.3%
  • Piotroski F-Score 7/9

Nicht bestanden (6)

  • P/B Ratio 5.69
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Earnings Surprise avg 0.3%
  • PEG Ratio 2.19

Nicht verfügbar (1)

  • Dividend Payout NaN%

Piotroski F-Score

7/9

Starke finanzielle Gesundheit

score
criteria

Gewinnqualität

1.39

Hohe Qualität: Gewinne durch Cashflow gedeckt

Aktienverwässerung

-1.2%

Aktienrückkäufe. Aktionärsfreundlich

Unternehmensführung

Führungsteam

NamePositionAlter
Mr. Sundaram NagarajanPresident, CEO & Director62
Mr. Daniel R. HopgoodExecutive VP & CFO52
Ms. Jennifer L. McDonough J.D.Executive VP, General Counsel & Corporate Secretary53
Mr. Joseph P. KelleyExecutive VP of Industrial Precision Solutions Leader52
Mr. Joseph M. RutledgeVP & Chief Accounting Officer45
Ms. Lara L. MahoneyVice President of Investor Relations & Corporate Communications-
Katie ColacarroVice President of Corporate Development-
Ms. Sarah SiddiquiExecutive VP & Chief Human Resources Officer47
Mr. Justin HallExecutive Vice President of Medical & Fluid Solutions46

Prüfungsrisiko

9

Vorstandsrisiko

3

Vergütungsrisiko

6

Aktionärsrechterisiko

10

Teil 2 · Der Preis und der Einstiegszeitpunkt

Dieser Teil sagt nicht, ob das Unternehmen etwas taugt: Er hilft bei der Wahl des Kaufzeitpunkts, nachdem die Fundamentaldaten überzeugt haben. Enthalten: technische Analyse, Potenzial, historische Drawdowns, Gamma-Exposure.

Latest News

Recent headlines for NDSN, sourced from Markets Gazette.

  • 4d agoPOSITIVE
    Thursday’s Activity, 4 Possible Friday Plays

    Nordson Corporation (NDSN) was highlighted as a potential multi-bagger opportunity in Thursday's trading session, with the NDSN Weekly $310-320 call options showing significant upside potential. The article suggests that the stock has delivered strong performance, aligning with the firm's successful track record of identifying profitable trading plays. Investors who followed this recommendation may have seen substantial gains, indicating positive momentum for the company's stock.

via Markets Gazette